1 Mona Abdel Salam Diabetes and Sarcopenic Risk.

2 Miram Bekhit Updates in Management of Diabetic Nephropathy

3 Iman Zaky Primary aldosteronism: An underestimatedrisk factor for Diabetes and CV Disease

4 Nabil El Naggar Atherosclerosis Paradox

5 Ibrahim Elebrashy Basal Insulin+GLP1-RA Fixed Ratio Combination advantagesin patients

6 Nermine Sheriba An oral hypoglycemic 60 years in the making:Glucokinase Activator

7 Ibrahim Elebrashy Oral Semaglutide: The first and only oral GLP1 RA

8 Megahed Abul Magd Beyond Glycemia: Rethinking diabetes remission from dreams torealities

9 Nabil El Kafrawy Take CareReal patients characteristics and prevalence of cardiorenal complication

10 Ibrahim Elebrashy Rosuvastatin Plain/Plus, Full Portfolio of highintensity lipid lowering therapy

11 Hesham El Gayar Dapagliflozin: A game changer for Cardio-renalMetabolic Syndrome in T2 DM

12 Mohamed Nabil El Naggar Management of Dyslipidemia in UK Lipid Clinics

13 Ashraf Reda Triglyceride reach Lipoproteins and CV risk

14 Mohamed Magdy Dietary Approach to type 2 Diabetes: Pros and Cons

15 Shrouk Moussa Diabetes in Athletes